Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
7,230,838
-
Total 13F shares
-
2,414,500
-
Share change
-
-202,413
-
Total reported value
-
$19,628,975
-
Price per share
-
$8.13
-
Number of holders
-
33
-
Value change
-
-$1,762,523
-
Number of buys
-
16
-
Number of sells
-
20
Institutional Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q3 2024
As of 30 Sep 2024,
Atara Biotherapeutics, Inc. - Common Stock (ATRA) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,414,500 shares.
The largest 10 holders included
EcoR1 Capital, LLC, Redmile Group, LLC, CITADEL ADVISORS LLC, BANK OF AMERICA CORP /DE/, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, ACADIAN ASSET MANAGEMENT LLC, Vestal Point Capital, LP, TANG CAPITAL MANAGEMENT LLC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
33
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.